NCT03789149: Focal Intraoperative Radiotherapy of Brain Metastases

NCT03789149
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Phase 2
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients with previous cranial radiotherapy
https://clinicaltrials.gov/show/NCT03789149

Comments are closed.

Up ↑